• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Firefly Neuroscience Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    11/1/24 4:05:33 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology
    Get the next $AIFF alert in real time by email
    wavd20241029_8k.htm
    false 0000803578 0000803578 2024-10-29 2024-10-29
     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     

     
    FORM 8-K
     

     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): October 29, 2024
     
     

     
    FIREFLY NEUROSCIENCE, INC.
    (Exact Name of Registrant as Specified in Its Charter)
     
     

     
    Delaware
     
    001-41092
     
    54-1167364
    (State or other jurisdiction
    of incorporation)
     
    (Commission
    File Number)
     
    (IRS Employer
    Identification No.)
     
     
    1100 Military Road
    Kenmore, NY
     
    14217
    (Address of principal executive offices)
     
    (Zip Code)
     
    Registrant’s telephone number, including area code: 888-237-6412
     
     
    (Former name or former address, if changed since last report)
     
     

     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
     
    Title of each class
     
    Trading
    Symbol(s)
     
    Name of each exchange
    on which registered
    Common Stock, $0.0001 par value per share
     
    AIFF
     
    The Nasdaq Capital Market
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     
     

     
     

     
     
    Item 4.01
    Changes in Registrant’s Certifying Accountant.
     
    (a) Dismissal of Independent Registered Public Accounting Firm
     
    On October 29, 2024, the Audit Committee (the “Audit Committee”) of the Board of Directors of Firefly Neuroscience, Inc. (the “Company”) dismissed Turner, Stone & Company LLP (“Turner Stone”) as the Company’s independent registered public accounting firm, effective immediately.
     
    The reports of Turner Stone on the Company’s consolidated financial statements for the years ended December 31, 2023, and December 31, 2022, did not contain an adverse opinion or a disclaimer of opinion, and was not qualified or modified as to uncertainty, audit scope, or accounting principles, except that Turner Stone’s reports for the years ended December 31, 2023, and December 31, 2022, each contained an explanatory paragraph stating there was substantial doubt about the Company’s ability to continue as a going concern.
     
    During the two most recent fiscal years ended December 31, 2023, and December 31, 2022, and the subsequent interim period through October 29, 2024, there were no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K of the Securities Exchange Act of 1934, as amended (“Regulation S-K”) and the related instructions to Item 304 of Regulation S-K) with Turner Stone on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Turner Stone, would have caused Turner Stone to make reference to the subject matter of the disagreements in connection with its reports on the Company’s consolidated financial statements for such years. Also during this time, there were no “reportable events,” as defined in Item 304(a)(1)(v) of Regulation S-K.
     
    The Company provided Turner Stone with a copy of the above disclosures and requested that Turner Stone furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the statements made above. A copy of Turner Stone’s letter dated October 31, 2024, is attached as Exhibit 16.1 to this Current Report on Form 8-K.
     
    (b) Appointment of New Independent Registered Public Accounting Firm
     
    On October 31, 2024, the Audit Committee engaged Marcum Canada, LLP (“Marcum”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, effective immediately. During the fiscal years ended December 31, 2023, and December 31, 2022, and the subsequent interim period through October 31, 2024, neither the Company nor anyone on its behalf has consulted with Marcum regarding (i) the application of accounting principles to any specified transaction, either completed or proposed or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, and neither a written report nor oral advice was provided to the Company that Marcum concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue, or (ii) any matter that was either the subject of a “disagreement,” as defined in Item 304(a)(1)(iv) of Regulation S-K, or a “reportable event,” as defined in Item 304(a)(1)(v) of Regulation S-K.
     
    Item 9.01
    Financial Statements and Exhibits.
     
    (d) Exhibits.
     
    Exhibit
    Number
     
    Description of Exhibit
    16.1
     
    Letter from Turner, Stone & Company LLP to the Securities and Exchange Commission dated October 31, 2024
    104
     
    Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
     

     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
         
       
    FIREFLY NEUROSCIENCE, INC.
         
    Date: November 1, 2024
    By:
    /s/ Jon Olsen
     
    Name:
    Jon Olsen
     
    Title:
    Chief Executive Officer
     
     
    Get the next $AIFF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIFF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AIFF
    SEC Filings

    View All

    Firefly Neuroscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

    2/4/26 4:16:04 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B5 filed by Firefly Neuroscience Inc.

    424B5 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

    2/3/26 4:45:06 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Neuroscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

    12/19/25 5:15:23 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Firefly Neuroscience Reports Third Quarter 2025 Financial Results

     – Quarterly performance characterized by higher revenues, reduced cost structure and improved bottom line – – Successful business integration drives 10.9% sequential quarter-over-quarter EEG/ERP scan volumes and 30% sequential revenue growth – KENMORE, N.Y., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today reported financial results for the three and nine months ended September 30, 2025. Business Highlights Third quarter 2025 revenue grew more than tenfold year-over-year and 30% s

    11/12/25 7:45:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

    KENMORE, N.Y. and MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced a new partnership with HealingMaps, the leading directory for ketamine, psychedelic-assisted therapy, and transcranial magnetic stimulation ("TMS") clinics, and Advanced Behavioral Strategies (ABS). The collaboration comes on the heels of HealingMaps and Capstone Management Group announcing their official launch of the Healing Health Alliance*, the first-of-its-kind Group Purchasing Organization ("GPO"

    9/5/25 7:55:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen 'CLEAR' Platform

    – Unlocks exciting new AI-driven brain biomarker discovery and advancement capabilities – – Substantial processing speed gains while maintaining high signal quality standards – – Comes just months after Firefly announced its acceptance into the NVIDIA Connect Program – KENMORE, Wash. and NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to unveil its new ‘CLEAR' (CLeaning EEG ARtifacts) Platform, a proprietary next-generation preprocessing techno

    8/26/25 7:45:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Menawat Arun Swarup

    4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

    10/30/25 3:48:32 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Posner Brian M

    4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

    10/30/25 3:47:39 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Vnook Stella

    4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

    10/30/25 3:46:24 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Financials

    Live finance-specific insights

    View All

    Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

    Company successfully listed on Nasdaq under the symbol "AIFF" Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company's dual go-to-market strategy TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced its financial results for the third quarter ended September 30, 2024, and provided a stockholder update. Firefly is dedicated to improving outcomes for people suffering wi

    11/14/24 5:30:18 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Leadership Updates

    Live Leadership Updates

    View All

    Stran & Company Appoints Veteran Financial Executive Brian M. Posner to its Board of Directors

    Quincy, MA, July 10, 2025 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ:SWAG) (NASDAQ:SWAGW), a leading provider of outsourced marketing solutions specializing in promotional products and loyalty incentives, today announced the appointment of Brian M. Posner, MBA, to its Board of Directors. Mr. Posner will serve as Chairman of the Audit Committee. Brian Posner brings over four decades of public company financial leadership, strategic planning, and investor relations experience to the Company. Currently, Mr. Posner serves on the Board of Directors of Firefly Neuroscience, Inc. (NASDAQ:AIFF), where he also chairs the Audit Committee. Firefly is an artificial

    7/10/25 8:00:00 AM ET
    $AIFF
    $SWAG
    Computer Software: Prepackaged Software
    Technology
    Advertising
    Consumer Discretionary

    Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman

    TORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of current director of the Board, Greg Lipschitz, as Executive Chairman, effective as of December 3, 2024. "I look forward to taking on a more active leadership role as Executive Chairman," said Greg Lipschitz, newly appointed Executive Chairman of Firefly. "I believe that Firefly is uniquely positioned at the intersection of artificial intelligence and brain health that I have l

    12/4/24 9:00:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors

    TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of Stella Vnook, Ph.D. to its Board of Directors, effective as of August 19, 2024. Dr. Vnook will serve as Chairperson of the Nominating Committee. Dr. Vnook brings over 25 years of experience as a distinguished pharmaceutical executive, serial entrepreneur, CEO and founder of multiple biotech companies and visionary leader with a track record of success in biotechnology and life

    9/5/24 9:00:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    9/19/24 9:48:56 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    8/21/24 6:07:51 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    8/21/24 6:03:49 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology